A phase I study of the fully human, fragment crystallizable- engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Vasu, Sumithira, Altman, Jessica K., Uy, Geoffrey L., Tallman, Martin S., Gojo, Ivana, Lozanski, Gerard, Burkard, Ute, Osswald, Annika, James, Pamela, Rüter, Björn, Blum, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883544/
https://www.ncbi.nlm.nih.gov/pubmed/34854276
http://dx.doi.org/10.3324/haematol.2020.274118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883544/
https://www.ncbi.nlm.nih.gov/pubmed/34854276
http://dx.doi.org/10.3324/haematol.2020.274118

Ejemplares similares